Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells

Acta Pharmacologica Sinica

Volumn 28, Issue 5, 2007, Pages 721-730

  Zou, Ke ^a,b   Ju, Ji Hang ^a,b   Xie, Hong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

5 fluorouracil; Apoptosis; Cell cycle; Insulin

Indexed keywords

CASPASE 3; DNA FRAGMENT; FLUOROURACIL; RECOMBINANT HUMAN INSULIN; THYMIDYLATE SYNTHASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL GROWTH; CELLULAR DISTRIBUTION; COLON CANCER; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ESOPHAGUS CANCER; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; NICK END LABELING; NITROBLUE TETRAZOLIUM TEST; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; INSULIN; THYMIDYLATE SYNTHASE;

EID: 34247607255     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00554.x     Document Type: Article

References (34)

1. Paradiso A, Xu J, Mangia A, Chiriatti A, Simone G, Zito A, et al. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5-FU/CPT-11 chemotherapy in advanced colorectal cancer patients. Int J Cancer 2004 111 : 252 8.
2. Fryar EB, Das JR, Davis JH, Desoto JA, Laniyan I, Southerland WM, et al. Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy. Anticancer Res 2006 26 : 1861 7.
3. Prevost A, Merol JC, Aime P, Moutel K, Roger-Liautaud F, Nasca S, et al. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP+5-FU versus CDDP+VP16 in advanced cancer of the head and neck. Oncol Rep 2005 14 : 771 6.
4. Fukushima M, Fujioka A, Uchida J, Nakagawa F, Takechi T. Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo. Eur J Cancer 2001 37 : 1681 7.
5. van Kuilenburg AB. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. Eur J Cancer 2004 40 : 939 50.
6. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003 3 : 330 8.
7. Loeffler M, Kruger JA, Niethammer AG, Reisfeld RA. Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 2006 116 : 1955 62.
8. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med 2002 53 : 615 27.
9. Shah MA, Schwartz GK. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res 2001 7 : 2168 81.
10. Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 2004 23 : 2934 49.
11. Makin G, Dive C. Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy Breast Cancer Res 2001 3 : 150 3.
12. De Meyts P. Insulin and its receptor: structure, function and evolution. Bioessays 2004 26 : 1351 62.
13. Furtado LM, Somwar R, Sweeney G, Niu W, Klip A. Activation of the glucose transporter GLUT4 by insulin. Biochem Cell Biol 2002 80 : 569 78.
14. Acevedo CG, Marquez JL, Rojas S, Bravo I. Insulin and nitric oxide stimulates glucose transport in human placenta. Life Sci 2005 76 : 2643 53.
15. Gu S, Villegas CJ, Jiang JX. Differential regulation of amino acid transporter SNAT3 by insulin in hepatocytes. J Biol Chem 2005 280 : 26055 62.
16. Al-Khalili L, Kotova O, Tsuchida H, Ehren I, Feraille E, Krook A, et al. ERK1/2 mediates insulin stimulation of Na(+), K(+)-ATPase by phosphorylation of the alpha-subunit in human skeletal muscle cells. J Biol Chem 2004 279 : 25211 8.
17. Rosic NK, Standaert ML, Pollet RJ. The mechanism of insulin stimulation of (Na+, K+)-ATPase transport activity in muscle. J Biol Chem 1985 260 : 6206 12.
18. Xu JM, Song ST, Tang ZM, Liu XQ, Jiang ZF, Zhou L, et al. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer. Breast Cancer Res Treat 1998 49 : 251 9.
19. Lautamaki R, Airaksinen KE, Seppanen M, Toikka J, Harkonen R, Luotolahti M, et al. Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. Diabetes 2006 55 : 511 6.
20. Sauer WH, Cappola AR, Berlin JA, Kimmel SE. Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. Am J Cardiol 2006 97 : 651 4.
21. Lasalvia-Prisco E, Cucchi S, Vazquez J, Lasalvia-Galante E, Golomar W, Gordon W. Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients. Cancer Chemother Pharmacol 2004 53 : 220 4.
22. Jiao SC, Huang J, Sun Y, Lu SX. The effect of insulin on chemo-therapeutic drug sensitivity in human esophageal and lung cancer cells. Zhonghua Yi Xue Za Zhi 2003 83 : 195 7. Chinese.
23. O'Connor PM, Kohn KW. A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells Semin Cancer Biol 1992 3 : 409 16.
24. Boumah CE, Setterfield G, Kaplan JG. Purine and pyrimidine analogues irreversibly prevent passage of lymphocytes from the G1 to the S phase of the cell cycle. Can J Biochem Cell Biol 1984 62 : 280 7.
25. Jedema I, Barge RM, Nijmeijer BA, Willemze R, Falkenburg JH. Recruitment of leukemic cells from G0 phase of the cell cycle by interferons results in conversion of resistance to daunorubicin. Leukemia 2003 17 : 2049 51.
26. Yuasa H, Matsuhisa E, Watanabe J. Intestinal brush border transport mechanism of 5-fluorouracil in rats. Biol Pharm Bull 1996 19 : 94 9.
27. Hickman JA. Apoptosis and chemotherapy resistance. Eur J Cancer 1996 32A : 921 6.
28. Amantana A, London CA, Iversen PL, Devi GR. X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 2004 3 : 699 707.
29. Adachi Y, Taketani S, Oyaizu H, Ikebukuro K, Tokunaga R, Ikehara S. Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8. Int J Oncol 1999 15 : 1191 6.
30. Yang Z, Cloud A, Hughes D, Johnson LF. Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene. Cancer Gene Ther 2006 13 : 107 14.
31. Curtin NJ, Harris AL, Aherne GW. Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res 1991 51 : 2346 52.
32. Mandel HG. The target cell determinants of the antitumor actions of 5-FU: does FU incorporation into RNA play a role Cancer Treat Rep 1981 65 Suppl 3 : 63 71.
33. Ota D, Kusama M, Kaise H, Nakayama S, Misaka T, Tsuchida A, et al. Evaluation of sensitivity to 5-FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase (DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer. Breast Cancer 2004 11 : 356 66.
34. van Triest B, Peters GJ. Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer. Oncology 1999 57 : 179 94.